In the OASIS-4 trial, about 74% of participants on oral semaglutide 25 mg experienced any GI adverse event versus 42% on placebo
Increased morbidity in overweight and obese liver transplant recipients: a single-center experience of 1325 patients from the United Kingdom
Furthermore, many included studies used either preceding or concurrent treatment to manage dumping syndrome so these outcomes cannot be completely attributed to the GLP-1 RM alone
Paying $180 at Peptide Sciences for the same compound available at $35 from Biotech Peptides (or even less from direct suppliers) raises legitimate questions about value
There was also an increase in plasma malondeldehyde showing improved recovery and also enhanced oxygen consumption to the cells in the body
Studies suggest it may support muscle repair, fat metabolism, bone strength, wound healing, and immune function